HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BAG3
BAG cochaperone 3
Chromosome 10 Β· 10q26.11
NCBI Gene: 9531Ensembl: ENSG00000151929.11HGNC: HGNC:939UniProt: O95817
350PubMed Papers
24Diseases
0Drugs
155Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Highly StudiedTrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein stabilizationprotein-macromolecule adaptor activitycytoplasmnucleusdilated cardiomyopathy 1HHmyofibrillar myopathy 6dilated cardiomyopathycardiomyopathy
✦AI Summary

BAG3 is a co-chaperone and adapter protein that functionally connects heat shock proteins (HSP70s and small heat shock proteins) to regulate protein homeostasis 12. As a nucleotide-exchange factor, BAG3 promotes ADP release from HSP70s by binding to their nucleotide-binding domain, triggering client protein release 13. BAG3 exhibits anti-apoptotic activity and regulates HSF1 nucleocytoplasmic transport 45. Clinically, BAG3 mutations cause multiple neuromuscular and cardiac diseases. BAG3 mutations are established causes of myofibrillar myopathy, characterized by Z-disk disintegration and myofibrillar degradation 67, and dilated cardiomyopathy with potential rapid progression 8. In cardiomyocytes, BAG3 loss increases transforming growth factor-Ξ² receptor 2 (TGFBR2) levels through reduced ubiquitination and degradation, promoting cardiac fibrosis 8. BAG3 also plays protective roles in neurodegeneration. Neuronal BAG3 attenuates tau hyperphosphorylation and cognitive deficits following traumatic brain injury by regulating autophagy-lysosome pathways 9. In Alzheimer's disease, astrocyte BAG3 induction enhances clearance of Ξ±-synuclein and tau through macroautophagy 10, while elevated BAG3 stabilizes BACE1, the rate-limiting amyloid-Ξ² generating enzyme 11.

Sources cited
1
BAG3 mutations are established causes of myofibrillar myopathy, characterized by Z-disk disintegration and myofibrillar degradation , , and dilated cardiomyopathy with potential rapid progression .
PMID: 39744939
2
Neuronal BAG3 attenuates tau hyperphosphorylation and cognitive deficits following traumatic brain injury by regulating autophagy-lysosome pathways .
PMID: 39394356
3
In Alzheimer's disease, astrocyte BAG3 induction enhances clearance of Ξ±-synuclein and tau through macroautophagy , while elevated BAG3 stabilizes BACE1, the rate-limiting amyloid-Ξ² generating enzyme .
PMID: 37315555
4
In Alzheimer's disease, astrocyte BAG3 induction enhances clearance of Ξ±-synuclein and tau through macroautophagy , while elevated BAG3 stabilizes BACE1, the rate-limiting amyloid-Ξ² generating enzyme .
PMID: 40408490
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜24
dilated cardiomyopathy 1HHOpen Targets
0.82Strong
myofibrillar myopathy 6Open Targets
0.79Strong
dilated cardiomyopathyOpen Targets
0.71Strong
cardiomyopathyOpen Targets
0.60Moderate
heart failureOpen Targets
0.58Moderate
hypertrophic cardiomyopathyOpen Targets
0.58Moderate
Abnormality of the cardiovascular systemOpen Targets
0.56Moderate
atrioventricular blockOpen Targets
0.49Moderate
familial dilated cardiomyopathyOpen Targets
0.48Moderate
myofibrillar myopathyOpen Targets
0.48Moderate
systolic heart failureOpen Targets
0.45Moderate
cardioverter defibrillatorOpen Targets
0.45Moderate
Parkinson diseaseOpen Targets
0.43Moderate
myocarditisOpen Targets
0.41Moderate
familial isolated dilated cardiomyopathyOpen Targets
0.37Weak
congestive heart failureOpen Targets
0.36Weak
Hernia of the abdominal wallOpen Targets
0.36Weak
nonischemic cardiomyopathyOpen Targets
0.36Weak
Premature atrial contractionsOpen Targets
0.35Weak
peripheral neuropathyOpen Targets
0.34Weak
Cardiomyopathy, dilated, 1HHUniProt
Charcot-Marie-Tooth disease, axonal, type 2JJUniProt
Myopathy, myofibrillar, 6UniProt
Neuronopathy, distal hereditary motor, autosomal dominant 15UniProt
Pathogenic Variants155
NM_004281.4(BAG3):c.1417C>T (p.Arg473Ter)Likely pathogenic
not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2026β†’ Residue 473
NM_004281.4(BAG3):c.77G>A (p.Trp26Ter)Pathogenic
Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Dilated cardiomyopathy 1HH
β˜…β˜…β˜†β˜†2026β†’ Residue 26
NM_004281.4(BAG3):c.1363G>A (p.Glu455Lys)Pathogenic
Primary dilated cardiomyopathy|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|not provided|Cardiovascular phenotype|Myofibrillar myopathy 6|Dilated cardiomyopathy 1HH
β˜…β˜…β˜†β˜†2026β†’ Residue 455
NM_004281.4(BAG3):c.367C>T (p.Arg123Ter)Pathogenic
Dilated cardiomyopathy 1HH|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2026β†’ Residue 123
NM_004281.4(BAG3):c.29_35del (p.Met10fs)Pathogenic
Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2025β†’ Residue 10
NM_004281.4(BAG3):c.626C>T (p.Pro209Leu)Pathogenic
Myofibrillar myopathy 6|not provided|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Peripheral neuropathy|Cardiovascular phenotype
β˜…β˜…β˜†β˜†2025β†’ Residue 209
NM_004281.4(BAG3):c.257dup (p.Tyr86Ter)Pathogenic
Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Cardiovascular phenotype
β˜…β˜…β˜†β˜†2025β†’ Residue 86
NM_004281.4(BAG3):c.625C>T (p.Pro209Ser)Pathogenic
Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|not provided|Abnormality of the musculature|BAG3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 209
NM_004281.4(BAG3):c.1408C>T (p.Pro470Ser)Pathogenic
Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2025β†’ Residue 470
NM_004281.4(BAG3):c.925C>T (p.Arg309Ter)Pathogenic
Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|Myocarditis;Primary dilated cardiomyopathy|Cardiovascular phenotype|BAG3-related disorder|Dilated cardiomyopathy 1HH
β˜…β˜…β˜†β˜†2025β†’ Residue 309
NM_004281.4(BAG3):c.715G>T (p.Glu239Ter)Pathogenic
not provided|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2025β†’ Residue 239
NM_004281.4(BAG3):c.268C>T (p.Arg90Ter)Pathogenic
not provided|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|Cardiovascular phenotype
β˜…β˜…β˜†β˜†2025β†’ Residue 90
NM_004281.4(BAG3):c.764G>A (p.Trp255Ter)Pathogenic
Cardiovascular phenotype|Primary familial dilated cardiomyopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 255
NM_004281.4(BAG3):c.361C>T (p.Arg121Ter)Pathogenic
Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|not provided|BAG3-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 121
NM_004281.4(BAG3):c.1067del (p.Pro356fs)Pathogenic
Primary dilated cardiomyopathy|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH
β˜…β˜…β˜†β˜†2025β†’ Residue 356
NM_004281.4(BAG3):c.252_258dup (p.Pro87fs)Pathogenic
Primary dilated cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2025β†’ Residue 87
NM_004281.4(BAG3):c.394C>T (p.Gln132Ter)Pathogenic
Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6
β˜…β˜…β˜†β˜†2025β†’ Residue 132
NM_004281.4(BAG3):c.699C>A (p.Tyr233Ter)Pathogenic
not provided|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Cardiovascular phenotype
β˜…β˜…β˜†β˜†2025β†’ Residue 233
NM_004281.4(BAG3):c.612del (p.Tyr205fs)Pathogenic
Primary dilated cardiomyopathy;Myocarditis|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH
β˜…β˜…β˜†β˜†2025β†’ Residue 205
NM_004281.4(BAG3):c.811C>T (p.Gln271Ter)Pathogenic
Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|Primary familial dilated cardiomyopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 271
View on ClinVar β†—
Related Genes
HSPA1AProtein interaction100%HSPA1LProtein interaction100%HSPA2Protein interaction100%HSPB2Protein interaction100%HSPB3Protein interaction100%BAG5Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Lung
48%
Brain
29%
Liver
25%
Ovary
19%
Bone Marrow
4%
Gene Interaction Network
Click a node to explore
BAG3HSPA1AHSPA1LHSPA2HSPB2HSPB3BAG5
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O95817
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.54Moderately Constrained
pLIβ“˜
0.92Intolerant
Observed/Expected LoF0.34 [0.23–0.54]
RankingsWhere BAG3 stands among ~20K protein-coding genes
  • #898of 20,598
    Most Researched350 Β· top 5%
  • #489of 5,498
    Most Pathogenic Variants155 Β· top 10%
  • #3,386of 17,882
    Most Constrained (LOEUF)0.54 Β· top quartile
Genes detectedBAG3
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology.
PMID: 37315555
Neuron Β· 2023
1.00
2
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy.
PMID: 39744939
J Clin Invest Β· 2025
0.90
3
The role of BAG3 in health and disease: A "Magic BAG of Tricks".
PMID: 33987872
J Cell Biochem Β· 2022
0.84
4
Neuronal BAG3 attenuates tau hyperphosphorylation, synaptic dysfunction, and cognitive deficits induced by traumatic brain injury via the regulation of autophagy-lysosome pathway.
PMID: 39394356
Acta Neuropathol Β· 2024
0.80
5
HSPB8 frameshift mutant aggregates weaken chaperone-assisted selective autophagy in neuromyopathies.
PMID: 36854646
Autophagy Β· 2023
0.76